| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 06, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$239.00
Est. +5%
|
$227.88 | $243.32 |
Precision Hit (±3%)
|
$230.59
+1.2%
|
| Apr 10, 2026 |
PTC Therapeutics Inc
PTCT
|
BUY |
$108.00
Est. +56%
|
$69.11 | $79.91 |
Pending
|
$76.77
+11.1%
|
| Apr 10, 2026 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$104.00
Est. +38%
|
$75.41 | $79.05 |
Pending
|
$73.96
-1.9%
|
| Apr 10, 2026 |
Rapport Therapeutics Inc.
RAPP
|
BUY |
$66.00
Est. +93%
|
$34.12 | $40.82 |
Pending
|
$38.40
+12.5%
|
| Feb 20, 2026 |
Insmed Inc
INSM
|
BUY |
$208.00
Est. +29%
|
$161.00 | $167.37 |
Pending
|
$97.46
-39.5%
|
| Jan 20, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$88.00
Est. +15%
|
$76.26 | $84.94 |
Pending
|
$68.00
-10.8%
|
| Dec 16, 2025 |
Insmed Inc
INSM
|
BUY |
$234.00
Est. +19%
|
$196.85 | $205.23 |
Pending
|
$97.46
-50.5%
|
| Nov 05, 2025 |
PTC Therapeutics Inc
PTCT
|
BUY |
$93.00
Est. +37%
|
$67.72 | $87.23 |
Pending
|
$76.77
+13.4%
|
| Sep 04, 2025 |
Wave Life Sciences Ltd.
WVE
|
BUY |
$18.00
Est. +125%
|
$8.00 | $21.72 |
Target Met
|
$6.00
-25.1%
|
| Aug 12, 2025 |
Insmed Inc
INSM
|
BUY |
$140.00
Est. +15%
|
$122.00 | $212.75 |
Target Met
|
$97.46
-20.1%
|
| Apr 25, 2025 |
United Therapeutics Corp
UTHR
|
BUY |
$314.00
Est. +8%
|
$291.38 | $607.89 |
Target Met
|
$549.57
+88.6%
|
| Jan 08, 2025 |
Verona Pharma Plc - ADR
VRNA
|
BUY |
$74.00
Est. +49%
|
$49.55 | $106.93 |
Target Met
|
$106.91
+115.8%
|
| Oct 17, 2024 |
Wave Life Sciences Ltd.
WVE
|
BUY |
$22.00
Est. +48%
|
$14.90 | $16.74 |
Miss
|
$6.00
-59.8%
|
| Aug 22, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$75.00
Est. +52%
|
$49.31 | $68.73 |
Miss
|
$67.99
+37.9%
|
| Aug 09, 2024 |
Insmed Inc
INSM
|
BUY |
$85.00
Est. +18%
|
$71.81 | $113.10 |
Target Met
|
$97.46
+35.7%
|
| Jun 12, 2024 |
United Therapeutics Corp
UTHR
|
BUY |
$350.00
Est. +27%
|
$275.76 | $417.82 |
Target Met
|
$549.57
+99.3%
|
| Jun 05, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$58.00
Est. +114%
|
$27.13 | $39.54 |
Miss
|
$68.00
+150.6%
|
| May 30, 2024 |
Inozyme Pharma Inc
INZY
|
BUY |
$14.00
Est. +210%
|
$4.51 | $6.24 |
Miss
|
$4.00
-11.3%
|
| May 29, 2024 |
Insmed Inc
INSM
|
BUY |
$77.00
Est. +44%
|
$53.55 | $84.87 |
Target Met
|
$97.46
+82.0%
|
| May 15, 2024 |
Wave Life Sciences Ltd.
WVE
|
BUY |
$11.00
Est. +88%
|
$5.84 | $16.74 |
Target Met
|
$6.00
+2.7%
|
| Apr 01, 2024 |
Insmed Inc
INSM
|
BUY |
$55.00
Est. +103%
|
$27.13 | $84.87 |
Target Met
|
$97.46
+259.2%
|
| Apr 01, 2024 |
Aerovate Therapeutics Inc
AVTE
|
BUY |
$35.00
Est. +18%
|
$29.57 | $1,134.70 |
Target Met
|
$2.68
-90.9%
|
| Dec 08, 2022 |
Prometheus Biosciences Inc
RXDX
|
BUY |
$142.00
Est. +21%
|
$117.21 | $199.96 |
Target Met
|
$199.92
+70.6%
|
| Sep 02, 2022 |
Forma Therapeutics Holdings Inc
FMTX
|
SELL |
$20.00
Est. +1%
|
$20.24 | $19.98 (Low) |
Bullseye Hit (±1%)
|
$20.01
+1.1%
|
| Nov 22, 2021 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$105.00
Est. +16%
|
$90.30 | - | - |
$55.65
-38.4%
|
| Sep 10, 2021 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$38.00
Est. +9%
|
$34.93 | - | - |
$41.03
+17.5%
|
| May 05, 2021 |
United Therapeutics Corp
UTHR
|
BUY |
$205.00
Est. +3%
|
$198.14 | - | - |
$549.57
+177.4%
|
| Apr 28, 2021 |
AMGEN Inc.
AMGN
|
BUY |
$259.00
Est. +13%
|
$229.35 | - | - |
$350.53
+52.8%
|
| Apr 26, 2021 |
Acceleron Pharma Inc
XLRN
|
BUY |
$151.00
Est. +19%
|
$126.67 | - | - |
$178.75
+41.1%
|